Kodiak Sciences Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from Kodiak Sciences Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
-9.6×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 51% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 2/3Sales grew in 0 of the last 3 years; profit grew in 2 of 3.
Less steady than 70% of Healthcare companies in United States.
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-11.3×Operating cash was negative last year, while some debt falls due within a year.
Higher than 53% of Healthcare companies in United States.
Cash Cushion Ratio
+3%Cash, after subtracting all debt, equals 3% of its market value (net cash).
Lower than 62% of Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (10)
Kodiak Sciences Inc. made a loss over the last year. Kodiak Sciences Inc. owes $0.76 for every $1 it owns. Kodiak Sciences Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossKodiak Sciences Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
90.14The share price is 90.14 times Kodiak Sciences Inc.'s book value per share, higher than almost all Healthcare companies in United States.
Market cap
$5.5 BThe total market value of all of Kodiak Sciences Inc.'s shares at today's price (share price × number of shares), larger than 85% of Healthcare companies in United States. PosiCap size class: Meso Cap.
Net worth (book value)
$61 MWhat Kodiak Sciences Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.97Net worth divided by the number of shares. The share price of $87.63 is 90.1 times this, which is the P/B above.
Return on equity (ROE)
-368.4%Kodiak Sciences Inc. lost 368.4% of its shareholders' money over the last year, lower than 91% of Healthcare companies in United States.
Owes vs Owns
0.76×Kodiak Sciences Inc. owes $0.76 for every $1 it owns (moderate), higher than 76% of Healthcare companies in United States.
Dividend yield
NoneKodiak Sciences Inc. does not currently pay a dividend.
Profit growth
LossKodiak Sciences Inc. made a loss in each of the last two years.
Cash vs debt
Net cashKodiak Sciences Inc. held $151 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For Kodiak Sciences Inc.: $5.5 B ÷ $61 M (30 Jun 2026) = 90.1.
What is Kodiak Sciences Inc.'s return on equity?
Kodiak Sciences Inc. lost 368.4% of its shareholders' money over the last year, lower than 91% of Healthcare companies in United States.
How much does Kodiak Sciences Inc. owe compared with what it owns?
Kodiak Sciences Inc. owes $0.76 for every $1 it owns (moderate), higher than 76% of Healthcare companies in United States.
Does Kodiak Sciences Inc. pay a dividend?
No. Kodiak Sciences Inc. does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.